Skip to main content

and
  1. Article

    Open Access

    The best linear unbiased prediction (BLUP) method as a tool to estimate the lifetime risk of pancreatic ductal adenocarcinoma in high-risk individuals with no known pathogenic germline variants

    Pancreatic ductal adenocarcinoma (PDAC) is the fourth leading cause of cancer-related death in the Western world. The number of diagnosed cases and the mortality rate are almost equal as the majority of patien...

    Cristina-Marianini-Rios, María E. Castillo Sanchez in Familial Cancer (2024)

  2. Article

    Open Access

    The Spanish Familial Pancreatic Cancer Registry (PANGENFAM): a decade follow-up of individuals at high-risk for pancreatic cancer

    The Spanish Familial Pancreatic Cancer Registry (PANGENFAM) was established in 2009 and aims to characterize the genotype and phenotype of familial pancreatic cancer (FPC). Furthermore, an early detection scre...

    Julie Earl, Raquel Fuentes, María E. Castillo Sanchez in Familial Cancer (2024)

  3. No Access

    Chapter

    Giant Macrophages: Characteristics and Clinical Relevance

    Tumor cell dissemination is mediated by a subpopulation of cells referred to as circulating tumor cells (CTCs), which have epithelial to mesenchymal properties and an inherent capacity to intravasate from the ...

    Julie Earl, Bruno Sainz Jr. in Atlas of Liquid Biopsy (2021)

  4. Article

    Open Access

    ISG15 and ISGylation is required for pancreatic cancer stem cell mitophagy and metabolic plasticity

    Pancreatic cancer stem cells (PaCSCs) drive pancreatic cancer tumorigenesis, chemoresistance and metastasis. While eliminating this subpopulation of cells would theoretically result in tumor eradication, PaCSC...

    Sonia Alcalá, Patricia Sancho, Paola Martinelli, Diego Navarro in Nature Communications (2020)

  5. No Access

    Article

    Tumor-associated macrophage-secreted 14-3-3ζ signals via AXL to promote pancreatic cancer chemoresistance

    Pancreatic ductal adenocarcinoma (PDAC) is an inherently chemoresistant tumor. Chemotherapy leads to apoptosis of cancer cells, and in previous studies we have shown that tumor-associated macrophage (TAM) infi...

    Gabriele D’Errico, Marta Alonso-Nocelo, Mireia Vallespinos, Patrick C. Hermann in Oncogene (2019)

  6. No Access

    Article

    Reply to ‘Mosaic loss of chromosome Y in leukocytes matters’

    Weiyin Zhou, Mitchell J. Machiela, Neal D. Freedman, Nathaniel Rothman in Nature Genetics (2019)

  7. Article

    Open Access

    Differential distribution and enrichment of non-coding RNAs in exosomes from normal and Cancer-associated fibroblasts in colorectal cancer

    Exosome production from cancer-associated fibroblasts seems to be an important driver of tumor progression. We report the first in-depth biotype characterization of ncRNAs, analyzed by Next Generation Sequenci...

    Mercedes Herrera, Carlos Llorens, Marta Rodríguez, Alberto Herrera in Molecular Cancer (2018)

  8. Article

    Open Access

    Erratum to: The UBC-40 Urothelial Bladder Cancer cell line index: a genomic resource for functional studies

    Julie Earl, Daniel Rico, Enrique Carrillo-de-Santa-Pau in BMC Genomics (2016)

  9. No Access

    Article

    Mosaic loss of chromosome Y is associated with common variation near TCL1A

    Meredith Yeager, Stephen Chanock and colleagues analyze mosaic loss of the Y chromosome in three prospective cohorts and observe association with age and smoking but not with cancer survival. They also identif...

    Weiyin Zhou, Mitchell J Machiela, Neal D Freedman, Nathaniel Rothman in Nature Genetics (2016)

  10. Article

    Open Access

    Erratum to: The UBC-40 Urothelial Bladder Cancer Cell Line Index: a genomic resource for functional studies

    Julie Earl, Daniel Rico, Enrique Carrillo-de-Santa-Pau in BMC Genomics (2015)

  11. Article

    Open Access

    Circulating tumor cells (CTC) and KRAS mutant circulating free DNA (cfDNA) detection in peripheral blood as biomarkers in patients diagnosed with exocrine pancreatic cancer

    Pancreatic cancer remains one of the most difficult cancers to treat with the poorest prognosis. The key to improving survival rates in this disease is early detection and monitoring of disseminated and residu...

    Julie Earl, Sandra Garcia-Nieto, Jose Carlos Martinez-Avila, José Montans in BMC Cancer (2015)

  12. Article

    Open Access

    The UBC-40 Urothelial Bladder Cancer cell line index: a genomic resource for functional studies

    Urothelial bladder cancer is a highly heterogeneous disease. Cancer cell lines are useful tools for its study. This is a comprehensive genomic characterization of 40 urothelial bladder carcinoma (UBC) cell lin...

    Julie Earl, Daniel Rico, Enrique Carrillo-de-Santa-Pau in BMC Genomics (2015)

  13. No Access

    Article

    Recurrent inactivation of STAG2 in bladder cancer is not associated with aneuploidy

    Francisco Real and colleagues report exome sequencing in urothelial bladder tumors. They show that STAG2, a subunit of the cohesin complex, is recurrently mutated and provide evidence that STAG2 loss does not lea...

    Cristina Balbás-Martínez, Ana Sagrera, Enrique Carrillo-de-Santa-Pau in Nature Genetics (2013)

  14. No Access

    Protocol

    Single-Nucleotide Polymorphism (SNP) Analysis to Associate Cancer Risk

    Identification of hereditary factors that predispose to cancer allows targeted cancer screening and better quantification of environmental risk factors. The ability to identify which single nucleotide polymorp...

    Julie Earl, William Greenhalf in Cancer Gene Profiling (2010)

  15. No Access

    Article

    Development of Temporal Temperature Gradient Electrophoresis for Characterising Methanogen Diversity

    Temporal temperature gradient electrophoretic (TTGE) analysis of 16S rDNA sequences was optimized to monitor the methanogen population present in water and sediments of a small eutrophic lake, Priest Pot, in t...

    Julie Earl, Roger W. Pickup, Donald A. Ritchie, Clive Edwards in Microbial Ecology (2005)